Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05390736 · ClinicalTrials.gov registry record · NA

Evaluating the Cost Effectiveness of STEADI

A NA study of Accidental Fall, sponsored by National Opinion Research Center.

Completed
Registry status
NA
Development phase
780
Enrollment target
1
Study location

NCT05390736: Completed NA study of Accidental Fall, sponsored by National Opinion Research Center.

NCT05390736 is a NA study of Accidental Fall that has completed, run by National Opinion Research Center. The registered enrollment target is 780 participants, above the 177-participant average among 9 other Accidental Fall trials with a reported enrollment target (341% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05390736, a NA study of Accidental Fall, has completed, sponsored by National Opinion Research Center.

COMPLETED
Registry status
NA
Development phase
780 participants
Enrollment target
1
Study location

Study Summary

Stopping Elderly Accidents, Deaths, and Injuries (STEADI) is an intervention to prevent falls among older adults developed by the Centers for Disease Control \& Prevention (CDC). Studies piloting the intervention have shown promising results; however, more evidence is needed to show that the intervention can be implemented cost-effectively on a larger scale in a real-world integrated health system. To this end, NORC partnered with Emory University School of Medicine to evaluate the effectiveness and cost-effectiveness of the STEADI intervention. This study aims to answer the following research questions to fill remaining knowledge gaps about STEADI: 1. Does STEADI significantly reduce falls among the target population compared to the standard of care? 2. Does partial implementation of some selected STEADI modules, also significantly reduce falls among the target population as compared to the standard of care? 3. Does the net present value of falls and resulting injuries averted by STEADI implementation exceed the net present value of the costs of STEADI implementation and the incremental costs that result from it? Using a mixture of qualitative interview and quantitative performance measures, the study evaluates and describes this case of STEADI implementation within selected primary care clinics of Emory Healthcare. NORC partnered with Emory University School of Medicine to implement different aspects of STEADI in a real-world primary care setting, document experiences implementing the intervention, measure implementation costs, and compare the outcomes of the STEADI intervention compared to control version of the intervention.

Primary Outcome

Falls identified in Emory Electronic Health Record as determined by the presence of ICD-10 diagnosis codes (W00-W19).

Conditions Studied

Interventions

  • BEHAVIORAL Gait and balance assessment
  • BEHAVIORAL Medication review
  • BEHAVIORAL Comorbidity review
  • BEHAVIORAL Fall history
  • BEHAVIORAL Assessment of feet/footwear

Study Locations (1)

Georgia

  • Emory Healthcare - Atlanta

Trial Details

FieldValue
Enrollment Target 780 participants
Start Date 2020-07-29
Est. Completion 2023-09-18
Phase NA
National Opinion Research Center

10 total trials

What the finished NCT05390736 record still lists

NCT05390736 is an interventional study that assigns participants to a tested intervention. The registered 780 participants enrollment target is mid-sized for trials with a published cap, above the 177-participant average among 9 other Accidental Fall trials with a reported enrollment target (341% higher).

The record links to 1 condition, with Accidental Fall appearing as the primary indexed condition, and to 5 interventions - of which Gait and balance assessment is the first listed.

NCT05390736 reports a single indexed study location in Georgia.

Frequently Asked Questions

What is clinical trial NCT05390736 about?

NCT05390736 is a clinical study titled "Evaluating the Cost Effectiveness of STEADI". Stopping Elderly Accidents, Deaths, and Injuries (STEADI) is an intervention to prevent falls among older adults developed by the Centers for Disease Control \& Prevention (CDC). Studies piloting the intervention have shown promising results; however, more evidence is needed to show that the interve...

What is the current status of trial NCT05390736?

This trial is currently completed. It is a NA study. The enrollment target is 780 participants. The study started on 2020-07-29. Estimated completion is 2023-09-18.

What conditions does trial NCT05390736 study?

This clinical trial studies the following conditions: Accidental Fall.

What interventions are being tested in trial NCT05390736?

The interventions under investigation include: Gait and balance assessment (BEHAVIORAL), Medication review (BEHAVIORAL), Comorbidity review (BEHAVIORAL), Fall history (BEHAVIORAL), Assessment of feet/footwear (BEHAVIORAL).

Who is sponsoring clinical trial NCT05390736?

This trial is sponsored by National Opinion Research Center, which has 10 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05390736 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Accidental Fall

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05390736's enrollment target sits among peer trials

780 1st of 9 higher than 9 of 9 other Accidental Fall trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Accidental Fall trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05046613 · 780 participants

    Observational Study to Assess Maternal, Fetal and Infant Outcomes Following Exposure to Rimegepant

  • NCT05100862 · 780 participants · Phase 3

    A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma

  • NCT05513872 · 780 participants · Phase 1

    Overcoming Nicotine Dependence to Enable Quitting

  • NCT06310031 · 780 participants · NA

    Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05390736, the US trial registry maintained by the National Library of Medicine. NCT05390736 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.